314 related articles for article (PubMed ID: 27875388)
21. Insight on the Intracrinology of Menopause: Androgen Production within the Human Vagina.
Cellai I; Di Stasi V; Comeglio P; Maseroli E; Todisco T; Corno C; Filippi S; Cipriani S; Sorbi F; Fambrini M; Petraglia F; Scavello I; Rastrelli G; Acciai G; Villanelli F; Danza G; Sarchielli E; Guarnieri G; Morelli A; Maggi M; Vignozzi L
Endocrinology; 2021 Feb; 162(2):. PubMed ID: 33247714
[TBL] [Abstract][Full Text] [Related]
22. Serum levels of sex steroids and metabolites following 12 weeks of intravaginal 0.50% DHEA administration.
Ke Y; Labrie F; Gonthier R; Simard JN; Bergeron D; Martel C; Vaillancourt M; Montesino M; Lavoie L; Archer DF; Balser J; Moyneur E;
J Steroid Biochem Mol Biol; 2015 Nov; 154():186-96. PubMed ID: 26291918
[TBL] [Abstract][Full Text] [Related]
23. Intracrinology and menopause: the science describing the cell-specific intracellular formation of estrogens and androgens from DHEA and their strictly local action and inactivation in peripheral tissues.
Labrie F
Menopause; 2019 Feb; 26(2):220-224. PubMed ID: 30130283
[TBL] [Abstract][Full Text] [Related]
24. Androgens in women are essentially made from DHEA in each peripheral tissue according to intracrinology.
Labrie F; Martel C; Bélanger A; Pelletier G
J Steroid Biochem Mol Biol; 2017 Apr; 168():9-18. PubMed ID: 28153489
[TBL] [Abstract][Full Text] [Related]
25. Effects of Tribulus terrestris on endocrine sensitive organs in male and female Wistar rats.
Martino-Andrade AJ; Morais RN; Spercoski KM; Rossi SC; Vechi MF; Golin M; Lombardi NF; Greca CS; Dalsenter PR
J Ethnopharmacol; 2010 Jan; 127(1):165-70. PubMed ID: 19781624
[TBL] [Abstract][Full Text] [Related]
26. The vagina as source and target of androgens: implications for treatment of GSM/VVA, including DHEA.
Cipriani S; Maseroli E; Ravelli SA; Vignozzi L
Climacteric; 2023 Aug; 26(4):309-315. PubMed ID: 37288964
[TBL] [Abstract][Full Text] [Related]
27. Intravaginal DHEA, by a strictly local action, exerts beneficial effects on both vaginal atrophy symptoms and sexual dysfunction.
Labrie F
Horm Mol Biol Clin Investig; 2010 Dec; 4(1):499-507. PubMed ID: 25961226
[TBL] [Abstract][Full Text] [Related]
28. A low dose (6.5 mg) of intravaginal DHEA permits a strictly local action while maintaining all serum estrogens or androgens as well as their metabolites within normal values.
Labrie F; Martel C
Horm Mol Biol Clin Investig; 2017 Feb; 29(2):39-60. PubMed ID: 27997350
[TBL] [Abstract][Full Text] [Related]
29. Dehydroepiandrosterone intra vaginal administration for the management of postmenopausal vulvovaginal atrophy.
Archer DF
J Steroid Biochem Mol Biol; 2015 Jan; 145():139-43. PubMed ID: 25201455
[TBL] [Abstract][Full Text] [Related]
30. Serum steroid concentrations remain within normal postmenopausal values in women receiving daily 6.5mg intravaginal prasterone for 12 weeks.
Martel C; Labrie F; Archer DF; Ke Y; Gonthier R; Simard JN; Lavoie L; Vaillancourt M; Montesino M; Balser J; Moyneur É;
J Steroid Biochem Mol Biol; 2016 May; 159():142-53. PubMed ID: 26972555
[TBL] [Abstract][Full Text] [Related]
31. Androgenic and estrogenic metabolites in serum of mice fed dehydroepiandrosterone: relationship to antihyperglycemic effects.
Leiter EH; Beamer WG; Coleman DL; Longcope C
Metabolism; 1987 Sep; 36(9):863-9. PubMed ID: 2957567
[TBL] [Abstract][Full Text] [Related]
32. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology.
Labrie F; Bélanger A; Cusan L; Candas B
J Clin Endocrinol Metab; 1997 Aug; 82(8):2403-9. PubMed ID: 9253308
[TBL] [Abstract][Full Text] [Related]
33. Almost exclusive androgenic action of dehydroepiandrosterone in the rat mammary gland.
Sourla A; Martel C; Labrie C; Labrie F
Endocrinology; 1998 Feb; 139(2):753-64. PubMed ID: 9449650
[TBL] [Abstract][Full Text] [Related]
34. Intravaginal dehydroepiandrosterone (Prasterone), a physiological and highly efficient treatment of vaginal atrophy.
Labrie F; Archer D; Bouchard C; Fortier M; Cusan L; Gomez JL; Girard G; Baron M; Ayotte N; Moreau M; Dubé R; Côté I; Labrie C; Lavoie L; Berger L; Gilbert L; Martel C; Balser J
Menopause; 2009; 16(5):907-22. PubMed ID: 19436225
[TBL] [Abstract][Full Text] [Related]
35. Intravaginal prasterone (DHEA) provides local action without clinically significant changes in serum concentrations of estrogens or androgens.
Labrie F; Martel C; Bérubé R; Côté I; Labrie C; Cusan L; Gomez JL
J Steroid Biochem Mol Biol; 2013 Nov; 138():359-67. PubMed ID: 23954500
[TBL] [Abstract][Full Text] [Related]
36. Expression of the estrogen receptors and steroidogenic enzymes involved in estradiol formation in the monkey vagina.
Bertin J; Ouellet J; Dury AY; Pelletier G; Labrie F
Am J Obstet Gynecol; 2014 Nov; 211(5):499.e1-9. PubMed ID: 24928055
[TBL] [Abstract][Full Text] [Related]
37. DHEA and the intracrine formation of androgens and estrogens in peripheral target tissues: its role during aging.
Labrie F; Bélanger A; Luu-The V; Labrie C; Simard J; Cusan L; Gomez JL; Candas B
Steroids; 1998; 63(5-6):322-8. PubMed ID: 9618795
[TBL] [Abstract][Full Text] [Related]
38. Influence of treatment of vulvovaginal atrophy with intravaginal prasterone on the male partner.
Labrie F; Montesino M; Archer DF; Lavoie L; Beauregard A; Côté I; Martel C; Vaillancourt M; Balser J; Moyneur E;
Climacteric; 2015; 18(6):817-25. PubMed ID: 26517756
[TBL] [Abstract][Full Text] [Related]
39. Expression of androgen receptors in the structures of vulvovaginal tissue.
Palacios S
Menopause; 2020 Nov; 27(11):1336-1342. PubMed ID: 33110052
[TBL] [Abstract][Full Text] [Related]
40. DHEA, important source of sex steroids in men and even more in women.
Labrie F
Prog Brain Res; 2010; 182():97-148. PubMed ID: 20541662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
